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Summary  
Chromatographic peak areas in long series of HPLC-MS experiments often vary, which 
decreases reproducibility and may cause bias in the results. It was found that the 
sensitivitiy of various components change differently; in our case variability is in the 
order of 20-40%; and it is most likely due to changing conditions in ESI ionization. The 
most often used peak area correction methods do not take this effect into account. The 
change in peak areas can be well described by a polynomial function; we found that a 4
th
 
order polynomial is most often suitable. We suggest a simple correction algorithm based 
on polynomial fitting. When the experiments were inherently well reproducible, this 
correction improved reproducibility from 12% to 3% (on average for various 
components). When random errors were larger, this improvement was less significant 
(15% to 12% in nano-ESI), but nevertheless essential in order to avoid possible bias in 
the results. 
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Introduction 
 
Various mainstream applications rely on long series of experiments using electrospray 
ionization (ESI
1
), typically with HPLC-MS(MS). Proteomics, metabolomics, 
pharmaceutical analysis and environmental monitoring are typical application fields 
needing long experimental sequences. ESI, and in particular nano-ESI, is known to have 
issues with long term stability
2
 and achieving long term stability is still an analytical 
challenge. There are many known (such as ion suppression, MS performance drift due to 
contamination of the ion source, ageing of the analytical column, etc.) and also unknown 
effects and parameters, which influence peak area, fragmentation and redox processes 
occurring in ESI. Among these spraying mode is an important, and well-studied effect
3,4
. 
Poor reproducibility due to unstable ESI conditions hinders quantitation (or semi-
quantitation), although the use of multiple internal standards
5
 or isotope-labelled methods 
(such as isotope coded affinity tags
6
 or universal metabolome-standard method
7
 in 
metabolomics) offer excellent possibilities in this regard. However, application of isotope 
labelling is often not possible (or not feasible).  
 
There are various attempts to improve stability/reproducibility of (nano)HPLC-
(nano)ESI-MS
8-10
; in particular in the field of metabolomics
11-15
. One of the most often 
used method is to use internal standards (IS). By selecting an internal standard similar to 
the studied compound, systematic batch-to-batch differences can be compensated. The 
chemicals of a very complex matrix, however, coeluting with the internal standard can 
cause ion suppression and therefore add systematic bias
5
. A further limitation, especially 
in the field of proteomics, is the lack of isotope labelled internal standards for most 
peptides and even more for modified peptides (like glycopeptides). Another alternative is 
to use the total intensity of the peaks; Wang at al. used total abundance regression 
calibration method to compensate for injection and other effects
13
. A significant 
limitation of methods using the total intensity of the peaks is, that it does not take into 
account the effect of individual peaks. If abundance of some peaks are increased while 
others are decreased these methods cannot correct it. In a recent publication Kuligowski
16
 
used δ statistics to detect batch effect in large data sets, but they did not propose a 
correction method. A popular alternative is to measure QC samples among the samples 
and use the intensity of QC peaks for correction
14,15
.  
 
In the present paper we address the issue of repeatability and reproducibility in long 
series of HPLC-MS experiments using both conventional and nano-electrospray. We 
focus on cases when relatively small differences among similar samples are studied: This 
is the case for most biomarker discovery studies, like identifying differences among 
plasma samples; or quality control of pharmaceutical products. Examples in proteomics 
and in pharmaceutical applications will be discussed.  
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Experimental 
 
Samples and chemicals 
Human blood plasma sample was obtained from a healthy volunteer from Bajcsy-
Zsilinszky Hospital, Budapest, Hungary (ethical permission number 1031-6/2012). The 
infliximab (Remicade) sample was obtained from Janssen Biotech (USA). 1,4-dithio-
L,D-threitol (DTT) and 2-iodoacetamide (IAA) were obtained from Fluka Chemie GmbH 
(Sigma-Aldrich®, Zwijndrecht, Netherlands). RapiGest SF (lyophilized sodium-3-[(2-
methyl-2-undecyl-1,3-dioxolan-4-yl)-methoxyl]-1-propane-sulfonate) was purchased 
from Waters (Milford, MA, USA). Mass spectrometry grade trypsin (Promega 
Corporation, Madison, WI, USA) was used. All other reagents were purchased from 
Sigma-Aldrich® (St. Louis, MO, USA). 
 
Sample preparation 
Plasma samples were depleted for albumin and IgG using Agilent Multiple Affinity 
Removal Spin Cartridge HSA/IgG (Agilent Technologies, Santa Clara, CA, USA), 
according the manufacturer’s standard protocol. Enzymatic digestion of depleted plasma 
samples and infliximab were performed using trypsin, according to the protocol described 
before
17,18
.  
 
LC-MS analysis 
HPLC-MS analysis of the infliximab digest was performed on a Nexera UPLC 
(Shimadzu Corporation) coupled to a high resolution micrOTOF-Q II mass spectrometer 
(Bruker Corporation). Chromatographic conditions were the following: the analytical 
column was a Kinetex reversed-phase column (1.7 µm XB-C18 particles, 2.1 mm i.d. × 
100 mm, Phenomenex Inc., CA, USA). Solvent A was water containing 0.1 v/v% formic 
acid and solvent B was 10% water and 90% acetonitrile containing 0.1 v/v% formic acid. 
The gradient was using 200 µL/min flow rate starting with a 8 min isocratic period with 
3% B, then a 50 min long gradient going to 50% solvent B. Washing was done using 7 
min long gradient from 50 to 100% solvent B, and kept there for 4 min. After that 
returning to 3% B in 1 min, and equilibration was done for 10 min. The column 
temperature was 30 °C. Mass spectrometric conditions: The mass spectrometer was used 
in positive electrospray ionization mode. Capillary voltage was 4.5 kV, nebulizer gas was 
1 bar, dry gas was 100 L/min, dry temperature 200 °C, end plate offset was 500 V. Scans 
were acquired in the 80-2200 m/z range. 
HPLC-MS analysis of the depleted plasma digest was performed on a nanoAcquity 
UPLC (Waters, Milford, MA, USA) coupled to a high resolution QTOF Premier mass 
spectrometer (Waters, Milford, MA, USA). Chromatographic conditions were the 
following: A Symmetry C18 trap column (180 µm i.d. × 20 mm, Waters Milford, MA, 
USA) was used, the analytical column was a reversed-phase column (C18, 1.7 µm BEH 
particles, 75 µm i.d. × 200 mm, Waters, Milford, MA, USA). Solvent A was water 
containing 0.1 v/v% formic acid and solvent B was acetonitrile containing 0.1 v/v% 
formic acid. The gradient was using 250 nL/min flow rate starting with a 4 min gradient 
from 3% to 8% B, then a 65 min long gradient going to 40% solvent B. Washing was 
done using 450 nL/min flow rate and a 2 min long gradient from 40 to 75% solvent B, 
and kept there for 18 min. After that returning to 3% B in 2 min, and equilibration was 
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done for 18 min. The column temperature was 55 °C. Mass spectrometric conditions: The 
mass spectrometer was used in positive electrospray ionization mode. Capillary voltage 
was 2.3 kV, nanoflow 1 bar, source temperature 90 °C, cone voltage 35 V. Single stage 
mass spectrometry in extended dynamic range mode was applied. Scans were acquired in 
the 500-2000 m/z range. 
 
Data evaluation 
In all cases chromatographic peak areas were measured, based on the most abundant 
isotope of the most abundant charge state of the protonated molecule (e.g. [M+3H]3+). In 
the Bruker instrument DataAnalysis Version 4.0 SP2 program was used for to determine 
peak areas. In the case of the Waters instrument an in-house developed software, 
GlycoPattern v.3.0
17
 was used to determine peak areas. The 4
th
 order polynomial fitting 
described in the text was performed using least squares minimization algorithm. 
Polynomial fitting and calculations based on Eq. 1 were facilitated by a VBA macro 
incorporated in an Excel worksheet. This Excel file is available from the authors on 
request.   
 
 
Results and discussion  
 
The first experiment to be discussed is analysis of a series of tryptic digests of infliximab, 
a pharmaceutical monoclonal antibody (mAb). The objective was to find small changes 
in the peptide digest due to sample storage at various temperatures. The digests were 
studied using UHPLC-ESI-MS on a Bruker QTOF instrument. The chromatograms were 
80 min long; altogether 57 HPLC-MS runs were performed in the course of a 4 day long 
experiment (see details in the Experimental section). The relative peak area of 18, 
randomly chosen components in the sample was evaluated; both major and minor peaks, 
eluting at various retention times; among them both peptides and glycopeptides. 
Chromatographic peak areas were calculated from the monitored signals of the most 
abundant isotopic peak of the protonated molecule in its most abundant charge state. Peak 
areas were normalized to their average area in the chromatographic series. 
 
In the course of the experimental sequence a reference compound (the same digest, stored 
at -20 C) was injected 13 times, approximately randomly distributed among the samples. 
The reproducibility/variability of various components in the reference sample were 
evaluated to assess the stability of HPLC-ESI-MS experiments, using peak areas of the 
18 selected components described above. Variability among these is characterized by the 
relative standard deviation; which is conventional. Similarity between the set of peak 
areas in two selected chromatograms may be compared by various methods; among these 
we have chosen the Pearson correlation coefficient; which is frequently used.  
 
Average relative standard deviation of peak areas, measured in absolute (arbitrary) units 
is 12%. Relative peak areas and their standard deviations are listed in Table 1. Most peak 
areas increase with time (in the sequence of the injections); but there are peaks which 
decrease in area along the injection series. Three such examples are shown in Fig. 1. This 
Figure clearly shows that there is an obvious time-dependence of the data; but the time 
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dependence is different for the various components. Note, all of the components studied 
are protonated peptides; i.e. they are chemically similar. Behavior of various components 
might be expected to be even more different if different compound types were studied. 
Note that no obvious correlation have been found between the properties of peptides 
(peptide size, sequence or polarity) and their changes of peak areas in a series of 
chromatograms.  
 
 
Fig. 1: Changes of peak areas in a series of chromatograms of infliximab digest, 
as a function of the injection sequence. Three chromatographic peaks were 
selected in the infliximab digest (Peaks # 4, 5 and 12 in Table 1). Peak areas were 
normalized to their average area in the series: (a) experimental data; (b) results 
after correction of time dependence. Experimental peak areas vary significantly in 
the experimental sequence (and each peak in a different manner), while only 
small random errors are present after time-correction. See details in text.  
 
 
 
The similarity between two individual chromatograms is often characterized by the 
Pearson correlation coefficient (R; note that often the square of this number, R
2
 is 
specified)
19
. These coefficients were calculated for all combinations of the 
chromatograms (13 chromatograms yield altogether 78 such values). These values are 
arranged in Fig. 2 as a function of the time difference between the chromatograms (blue 
open circles). The correlation coefficient shows good overall similarities (the R value is 
well above 0.99 in all cases). However, the correlation coefficient decreases significantly 
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with increasing time between individual sample injections. In other words, when the time 
between individual chromatograms is short, these are similar; but when long time has 
elapsed between two chromatographic runs, these start to become different.  
 
  
 
Fig. 2: Pearson correlation coefficients (R) between various pairs of reference 
chromatograms in a series of infliximab digest, shown as a function of the time-
difference between the individual injections (measured by difference in sequence 
number of the chromatograms). Blue open circles represent original data; red 
triangles show the result after correcting peak areas for their time-dependence. 
The Figure shows that the difference between pairs of chromatograms increases, 
when the time between them increases; but this can be well compensated.  
 
 
Figs. 1 and 2 suggest that the major source of variability of peak areas (as measured by 
the relative standard deviations in Table 1) is due to the time-dependence of the 
experiments, and not due to random errors. It follows, that taking into account the time 
dependence of chromatograms (i.e. that of changes in mass spectrometer conditions) this 
error might be compensated. This would have three major consequences: (1) This would 
improve reproducibility and repeatability (measured by relative standard deviation); (2) 
eliminate a major source for “bias” (e.g. mistakenly evaluating time-dependence as a 
certain biological/chemical effect); and (3) may help standardizing experiments run on 
different instruments or in different laboratories. Note that time dependence of each 
individual peak (identified by retention time and m/z value) should be considered 
separately; as they may change differently in time (Fig.1).  
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In order to compensate for time-dependence, a reference sample should be measured at 
various times in the experimental sequence. The reference samples should be similar to 
the samples studied (should contain the same components, although the abundance of 
these components in not essential). Ideally a pool of the samples to be studied should be 
used; although samples from a control experiment may be equally suitable. Conventional 
quality control (QC) samples (like a synthetic peptide mixture, or an enolase digest) may 
not help in this respect, as sensitivity of various compounds changes differently.  
 
We suggest a simple algorithm to correct the time-dependence (changing MS conditions) 
discussed above. We measure the peak area of a selected ion signal in the reference 
sample (like that in Fig. 1); and describe its time dependence with a polynomial (linear or 
quadratic would be well suited for those shown in Fig. 3). Parameters of the polynomial 
were determined by least squares fitting. Subsequently we correct the measured peak 
areas (both in the case of reference and “real” samples) according to the following 
equation:  
 
  
       
      
    
    
      (1) 
 
Where Ax
corr
 is the corrected peak area of the selected ion at the x-th chromatogram in the 
series; Ax
meas
 is the measured peak area in the x-th chromatogram; Aavr is the averaged 
peak area in the series of reference compound measurements; and f(x) is the expected 
peak area of the reference compound if it were measured in the x-th chromatogram, based 
on the fitted polynomial function. Note that, in our case retention time shifts are small, on 
average 0.4%, therefore no corrections were necessary.  
 
Data in Fig. 1 could be well approximated by a linear function, but the time dependence 
is not always so straightforward. We have studied a number of chromatogram series (the 
instrument is never tuned during a given series of chromatographic runs); and some other 
examples will be discussed below. In our experience the change in signal dependence 
could be well fitted to a 4
th
 power function in all cases. If there are more than ca. 10-12 
reference chromatograms studied, there is no serious problems with over-fitting. Using 
the 4
th
 order polynomial function with Equation 1 (the fitted polynomial curves are 
shown in Fig. 1), we have corrected the measured peak areas in the experiment described 
above. Taking into account time-dependence using this simple correction algorithm 
decreases the average relative standard deviation of peak areas from 12% to 3% (Table 
1). We have also compared the similarity of various chromatograms using the Pearson 
correlation coefficients, as described above. The correlation coefficients improve 
significantly, and are better than 0.999 in all cases, even when several days elapse 
between injections. The data after time-correction are shown by the red triangles in Fig. 
2. These results indicate that the time dependence (i.e. variability of mass spectrometer 
conditions) has clearly been well-compensated by the simple algorithm suggested.  
 
A different, experimentally more demanding example is encountered in the case of 
glycosylation analysis of plasma proteins. Tryptic digests of a depleted plasma sample 
were measured and the glycosylation patterns were studied based on 16 glycopeptide 
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peak areas (like before, based on relative chromatographic peak area of the most 
abundant isotope of the protonated molecule in the most abundant charge state). These 
experiments have been performed on a nano-UHPLC on a Waters QTOF instrument. 
Altogether 52, individually 120 min long chromatograms were studied, the objective was 
to determine reproducibility of various sample preparation steps. Sample preparation may 
result in sample loss; which was compensated by normalizing the results (set of selected 
ion peak areas) to the sum of the 16 peak areas studied. Partly due to the use of nano-ESI 
(which is known to be much less robust than conventional ESI); partly due to random 
errors in sample preparation; and partly because many of the studied peaks were close to 
the detection threshold, the overall scattering of the data is significantly larger than that 
discussed above. The results in one example (the biantennary, twice sialylated glycoform 
of the MVSHHNLTTGATLINEQWLLTTAK peptide derived from haptoglobin) are 
shown in Fig. 3. The uncorrected results (blue circles) show significant time-dependence; 
which can be well represented by a 4
th
 order polynomial (dotted line). Time dependence, 
as before, is different for the various ions considered. Correcting the data for time-
dependence (using Eq. 1) results in the red triangles in Fig. 3. Although the scattering of 
data is significant (especially compared to Fig. 1); the time dependence is well taken care 
of. In this case the average relative standard deviation of uncorrected peak areas is 15%; 
time correction reduces this to 12%. This improvement is much less striking, than those 
discussed in the previous case; mainly due to large overall random errors. Nevertheless, 
systematic errors can be compensated this way, and that may be very important for 
avoiding bias. Note that in this case systematic errors (those, which are nearly completely 
removed by the correction) are of similar size than random errors; the relatively small 
improvement is due to the laws of error propagation. 
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Fig. 3: Changes of relative peak areas in a series of chromatograms of all plasma 
digests. The selected peak is the biantennary, twice sialylated glycoform of the 
MVSHHNLTTGATLINEQWLLTTAK peptide derived from haptoglobin. Blue 
open circles indicate measured peak areas; red triangles those after time-
correction. The blue dots show the 4
th
 order polynomial used to describe time-
dependence. The results are plotted as a function of injection sequence. Random 
errors are significant even after time-correction, but the systematic change in peak 
areas (which may cause bias in the results) is removed.  
 
In the paragraphs above, we have shown time dependence (and its correction) for the 
main charge state of various compounds. We have checked other charge states as well, 
and found that various charge states of the same compound show different evolution in 
time. This suggests, that time dependence is predominantly due to changes in mass 
spectrometric (electrospray) conditions. In some cases increase in the peak area of e.g. 3+ 
state was accompanied with decrease in the peak area of the 2+ charge state, (one such 
example is shown in Fig. 4, which illustrates the (absolute, uncorrected) peak areas of #6 
VYACEVTHQGLSSPVTK peptide in Table 1) but our data do not suggest that this 
could be generalized. When necessary, the various charge states could be treated 
(corrected) separately. For relative quantitation (e.g. amount of the analyte in sample #1 
compared to sample #2) measuring the peak areas of any charge state (or the sum of all 
charge states) is equally suitable. Absolute quantitation (provided that suitable, preferably 
isotope labeled internal standard is available) can also be based on the peak area of any 
charge state. For this reason, for analytical purposes, it is sufficient to characterize (and 
correct) the time behaviour of an arbitrarily selected charge state only.  
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In Figs. 1-3 we have shown relative peak areas; as we believe those are most useful for 
analytical purposes. Normalizing data to the sum of all peak areas is common practice. 
This removes some of the errors in sample preparation and sample injection; which errors 
are independent of the time-dependence studied here, and may be important in practice. 
Normalization also removes errors due to long-term change in overall mass spectrometric 
sensitivity. This may be combined with the 4
th
 degree polynomial fitting suggested in the 
present paper. We have checked, that (when there are no errors due to sample 
preparation) the results of the 4
th
 degree polynomial fitting with or without normalization 
are very similar. Overall sensitivity in long series of MS measurements often shows a 
decreasing trend (i.e. decreasing MS performance). However, it is not always the case. 
The experiment series discussed in Figs. 1, 2 and 4, for example, shows an increasing 
trend in overall sensitivity (Fig. 4, middle curve).  
 
 
Fig. 4: Changes of peak areas of infliximab in a series of chromatograms, as a function of 
the injection sequence. Different charge states of VYACEVTHQGLSSPVTK peptide (#6 
in Table 1) are represented using blue dots: m/z 625.98 3+; and green squares: m/z 
938.47 2+. The data show that when peak area of 3+ charge state increases, then area of 
2+ decreases. Red triangles indicates the sum of peak areas of all peptides (divided by 10) 
showing that overall sensitivity increases. 
 
 
Conclusions 
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Long experimental sequences, lasting several days or more are becoming common 
practice in HPLC-MS, especially in proteomics, in metabolomics and in pharmaceutical 
quality control. The experimental conditions may subtly change during this time, which 
may result in a systematic change of relative peak areas. This effect was illustrated in two 
cases: (a) looking at various peptides in an infliximab digest, using a conventional ESI 
source; and (b) glycopeptides in a human plasma digest using nano-ESI ion source; on a 
Bruker and a Waters instrument, respectively. Both experiments lasted 3-4 days, and 
chromatographic peak areas (measured in selected ion chromatograms) of various 
components were monitored. Evaluation of the results showed that:  
a) Peak areas vary in time; this may be close to linear (Fig. 1) or may be more 
complex (Fig. 3). In the present example the systematic change was in the order 
of 20-40% for most components (resulting in 10-20% relative standard deviation). 
Results obtained with a conventional and a nano-ESI source were comparable in 
this respect. The similarity between individual chromatograms decreases when the 
time between the chromatograms increases (Fig. 2). The most likely reason for the 
time-dependence is changing conditions in ESI ionization. When tuning in the ion 
source was intentionally changed (like capillary voltage, nebulizer pressure, etc.), 
this resulted in a similar difference in peak areas as that observed in the course of 
several days.  
b) The change of peak areas in time is different for the various components (Fig. 1). 
Here only protonated molecules were studied; the change in the case of fragment 
ions or molecular adducts may be even more significant. Note that most existing 
peak area correction methods do not take this into account and may lead to 
significant bias. 
c) The time dependence can be described in all cases studied by a 4th order 
polynomial function (this includes various examples in our laboratory, not only 
those described in the present paper). A simple correction function (Eq 1) is 
suggested, which removes the time-dependence from the data. When random 
errors are small, this leads to a dramatic improvement of reproducibility (12 to 3% 
rsd, Fig. 1). When random errors are large, improvement in reproducibility is 
modest (15 to 12% rsd, Fig. 3). Nevertheless, correction is important in this case 
as well, as it removes a major source for bias in the experiment sequence.  
d) Correcting the time dependence of the data relies on the use of a reference 
compound; which should be injected various times during the experiment 
sequence. The reference sample should be similar and should contain all 
components monitored in the sample. Ideally it is expedient to inject a reference 
sample after 3-5 samples. If a 4
th
 order polynomial function is used to describe 
time dependence, at least 10-15 reference samples should be run, to avoid over-
fitting the parameters.  
e) The same reference sample may be used to improve comparison of different series 
of HPLC-MS runs; like experimental series running for several month or improve 
inter-laboratory comparisons. For each monitored compound the average peak 
area in the reference sample (in a given HPLC-MS series) is measured, and is 
compared to that measured in a different HPLC-MS series (A
ref
(1) and A
ref
(2), 
respectively). The ratio of the two values characterizes the relative sensitivity (for 
the selected compound) in the two experiment series. To make sample peak areas 
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comparable in the second series to that observed in the first series, the following 
equation may be used:  
               
 
   
   
       
    (2) 
 
Where A
meas
(2) is the measured (time-corrected) peak area of a selected 
component in a sample measured in the #2
nd
 series of experiments; while A
mod
 is 
its modified value comparable in scale with experiments in a different series (or in 
a different laboratory). 
When similar samples are studied, the suggested method may be applied without using 
quality control samples; although the correction will be less accurate. In such a case (for 
the purpose of correcting instrumental variability) all samples are considered being 
identical (as if all were QC samples). Correction (using a polynomial) is performed, as 
described above. After correction, the remaining variability in the data set is equated with 
the biological variability among the samples. Note that in this case it is particularly 
important that samples should be measured in a random order; and that correction will be 
less reliable. Our experience suggests that without QC samples 50-70% of the 
instrumental variability may be expected to be removed this way.  
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